Codiak BioSciences names winning bidders for five sets of assets

By Sarah Lizee

Olympia, Wash., May 26 – Codiak BioSciences, Inc. named the winning and backup bidders for five sets of its assets in a notice filed Thursday with the U.S. Bankruptcy Court for the District of Delaware.

The winning bids include Lonza Houston, Inc.’s $3.4 million bid for lots four and five, Evox Therapeutics Ltd.’s $2.09 million bid for lots two and three, and Astellas Institute for Regenerative Medicine’s $50,000 bid for lot one.

Hercules Capital, Inc. is the backup bidder for all five sets of assets. The bid is a $5 million credit bid.

A sale hearing is scheduled for May 31.

Codiak BioSciences is a clinical-stage biopharmaceutical company based in Cambridge, Mass. The company filed bankruptcy on March 27 under Chapter 11 case number 23-10350.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.